Beyond Glucose Control: A Comprehensive Review of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Heart Failure, Chronic Kidney Disease, and Nonalcoholic Fatty Liver Disease - Cureus

मार्च 2, 2026 Last updated : मार्च 2, 2026 health.aiweekly.co.in

Beyond Glucose Control: A Comprehensive Review of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Heart Failure, Chronic Kidney Disease, and Nonalcoholic Fatty Liver Disease  CureusView Full coverage on Google News

श्रेणी
Uncategorized
Previous article
Etiology Linked With Neurologic Recovery for Patients With Status Epilepticus - Docwire News
मार्च 2, 2026
Next article
Women May Be at Risk of Heart Attacks With Lower Plaque Levels Than Men, New Study Finds - Flow Space
मार्च 2, 2026